April 25 (Reuters) - Theravet SA ALVET.PA :
* THERAVET REPORTS FULL-YEAR 2022 FINANCIAL RESULTS AND
PROVIDES
THE PREPARATORY DOCUMENTS FOR THE GENERAL ASSEMBLY OF JUNE 1ST,
2023
* CASH POSITION OF EUR 3.19 MILLION AT DECEMBER 31, 2022,
GIVING
FINANCIAL VISIBILITY UP TO BEGINNING OF 4(TH) 2024 QUARTER
* 2022 SALES PERFORMANCE WITHIN TARGETS IN EUROPEAN MARKET
* STAFF EXPENSES INCREASED TO EUR 0.36 MILLION AS COMPARED
TO 2021
AS RESULT OF STRENGHTENING OF COMPANY ORGANIZATION
* FY OPERATING LOSS OF EUR 2.8 MILLION AND A NET LOSS OF EUR
2.3
MILLION
* FY EBITDA LOSS EUR 1.7 MILLION VERSUS LOSS EUR 1.2 MILLION
YEAR
AGO
Source text for Eikon: ID:nBw6J2gh0a
Further company coverage: ALVET.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))